GEORGE VALIENTE: Open Payments
NPI 1538657127 · PEMBROKE PINES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$624 in 16 payments from 9 companies in 2025. Trend: 2023 $59 · 2024 $216 · 2025 $624
Food & beverage: $449Education: $175
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $179 |
| Janssen Biotech, Inc. | 2 | $145 |
| SEAGEN INC. | 1 | $80 |
| Legend Biotech USA Inc. | 2 | $61 |
| Incyte Corporation | 2 | $48 |
| Blueprint Medicines Corporation | 2 | $46 |
| Daiichi Sankyo Inc. | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| BeOne Medicines USA, Inc. | 1 | $15 |
Products named: RYBREVANT, CARVYKTI, Cresemba, AYVAKIT, Enhertu, MONJUVI, JAKAFI, KISQALI.
Industry payments across FL — which companies pay providers there.
